COMMUNIQUÉS West-GlobeNewswire

Stryker increases dividend 11%, declaring a $0.52 per share quarterly dividend

04/12/2018 - 21:30

Kalamazoo, Michigan, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – December 4, 2018 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share [...]

Tetra Bio-Pharma Responds to Shareholders

04/12/2018 - 18:36

“Tetra is Not a Cannabis Company” Says CEO Chamberland ORLEANS, Ontario, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or “ TBP ”), (TSX VENTURE: TBP) (OTCQB: TBPMF) - Recent news regarding Aphria [...]

Data for BeyondSpring’s Lead Asset, Plinabulin, for Chemotherapy-Induced Neutropenia (CIN) Prevention Shows Differentiated Profile Compared with G-CSF and Adds Additional Protection to G-CSF

04/12/2018 - 18:35

BeyondSpring Presented Latest Clinical Results at 2018 American Society of Hematology (ASH) Annual Meeting Plinabulin monotherapy is an equally effective single-dose-per cycle agent as pegfilgrastim, but with minimal [...]

Holding(s) in Company

04/12/2018 - 18:20

Holding(s) in Company December 4, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Shire plc (LEI: [...]

Allscripts to present at the Citi 2018 Global Healthcare Conference

04/12/2018 - 18:15

CHICAGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the Citi 2018 Global Healthcare Conference in New York, NY on Thursday, [...]

Agility Health Subsidiaries File Notice of Intention to Make a Proposal Under the Bankruptcy and Insolvency Act (Canada)

04/12/2018 - 18:04

HAMILTON, Ontario, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or “ Company ”) announces that on December 3, 2018, four of the Company’s operating subsidiaries; Ontario [...]

VALNEVA to Conduct Investor and Partnering Meetings During the 37th Annual J.P. Morgan Healthcare Conference

04/12/2018 - 17:51

Valneva to Conduct Investor and Partnering Meetings During the 37 th Annual J.P. Morgan Healthcare Conference Saint-Herblain (France), December 4, 2018 - Valneva SE ("Valneva"), a biotech company developing and [...]

VALNEVA rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference

04/12/2018 - 17:51

Valneva rencontrera investisseurs et partenaires potentiels lors de la J.P. Morgan Healthcare Conference Saint-Herblain (France), 4 décembre 2018 - Valneva SE ("Valneva"), société de biotechnologie développant et [...]

Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital and Announces Capital Update for the Celiac Disease Clinical Program and its NASH Development Strategy on December 17, 2018

04/12/2018 - 17:15

-- Announces collaboration in high unmet need Alcoholic Liver Diseases (ALD), including severe alcoholic hepatitis, with novel gut-specific, clinical-stage asset, larazotide acetate -- Investor update on capital plan [...]

CAPS® Expands National Footprint, Opens New 503B Compounding Outsourcing Facility in Phoenix

04/12/2018 - 16:57

New facility brings nearly 400 jobs and the latest engineering and technology in sterile compounding to the western U.S. IRVINE, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS [...]

Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company

04/12/2018 - 16:49

Company Announcement Claus Frisenberg Pedersen, CCO in Oncology Venture buys shares in the Company Hoersholm, Denmark – December 4, 2018 – Oncology Venture A/S (OV:ST) announces that CCO Claus Frisenberg Pedersen has [...]

The Alliance for Regenerative Medicine Announces 2019 Cell & Gene Therapies State of the Industry Briefing

04/12/2018 - 16:46

WASHINGTON, D.C., Dec. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapies and broader [...]

Peter Buhl Jensen, CEO in Oncology Venture buys shares in the Company

04/12/2018 - 16:19

Company Announcement Peter Buhl Jensen, CEO in Oncology Venture buys shares in the Company Hoersholm, Denmark – December 4, 2018 – Oncology Venture A/S (OV:ST) announces that CEO Peter Buhl Jensen, through Buhl Krone [...]

Precipio Announces $1.2 Million Securities Purchase Agreement With Participation from Members of Its Board of Directors, and other Investors

04/12/2018 - 15:15

NEW HAVEN, Conn., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that it has entered into a $1.2 million Securities Purchase Agreement with several [...]

Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA (mRNA) Therapeutics Platform (MRT™)

04/12/2018 - 15:15

Patent Supports Foundational Intellectual Property and Pioneering Work in Liver Delivery for mRNA Therapeutics LEXINGTON, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger [...]

Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock

04/12/2018 - 15:14

MINNEAPOLIS, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Admera Health Adds Clinical Genomics Expert, Dr. Ruben Bonilla-Guerrero, to Management Team

04/12/2018 - 15:13

SOUTH PLAINFIELD, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostic company, welcomes Dr. Ruben Bonilla-Guerrero as Medical Director to the company. Ruben Bonilla-Guerrero obtained his M.D. [...]

New Proximity Systems Open-Arm Cabinet Meets Space Constraints of Shrinking Patient Rooms

04/12/2018 - 15:00

Flexible workstation mount is ergonomically designed to improve ability of hospital staff to interact with patients TOMBALL, Texas, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Proximity Systems, Inc., the leading provider of [...]

Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma

04/12/2018 - 14:30

Patient enrolled at highest fractionated two-dose regimen to date FLORHAM PARK, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the [...]